News - Center for Reproductive Health Sciences

Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress (Mol. Cancer Res., (2026), 24, (198))
February 28, 2026
Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and […]
DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells
December 1, 2025
DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor CellsLesage, J., Dimauro, […]
Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response
September 14, 2025
Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy ResponseValentine, M. […]
From one-size-fits all to biology-driven care: Emerging paradigms in gynecologic oncology
August 31, 2025
From one-size-fits all to biology-driven care: Emerging paradigms in gynecologic oncologyMullen, M. M. & Arend, R. C., […]